HomeGeneticsGeneMCOLN1 gene
Back to Gene
MCOLN1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

MCOLN1 gene

The MCOLN1 gene provides instructions for making the mucolipin-1 protein, which is essential for lysosomal function and the maintenance of brain and retinal health.

Normal Function

The MCOLN1 gene provides instructions for making a protein called mucolipin-1. This protein is located in the membranes of lysosomes and endosomes, compartments within the cell that digest and recycle materials. While its function is not completely understood, mucolipin-1 plays a role in the transport (trafficking) of fats (lipids) and proteins between lysosomes and endosomes.

Mucolipin-1 acts as a channel, allowing positively charged atoms (cations) to cross the membranes of lysosomes and endosomes. It remains unclear which cations are allowed to flow through this channel. Mucolipin-1 appears to be important for the development and maintenance of the brain and light-sensitive tissue at the back of the eye (retina). In addition, this protein is likely critical for normal functioning of the cells in the stomach that produce digestive acids.

Health Conditions Related to Genetic Changes

Mucolipidosis type IV

At least 22 mutations in the MCOLN1 gene have been found to cause mucolipidosis type IV. Most of these mutations result in the production of a nonfunctional protein or prevent any protein from being produced.

  • Two mutations account for almost all cases in people with Ashkenazi Jewish ancestry.
  • The most common mutation, 406-2A>G, is a splice-site mutation that introduces a premature stop signal.
  • Another mutation, 511_6943del, deletes a large amount of DNA near the beginning of the gene.

A lack of functional mucolipin-1 impairs the transport of lipids and proteins, causing these substances to build up inside lysosomes. It remains unclear how these mutations lead to delayed development of mental and motor skills (psychomotor delay), progressive vision loss, and impaired secretion of stomach acid (achlorhydia).

Frequently Asked Questions

Currently, no specific diet or medication targets the underlying lysosomal dysfunction. Supportive care includes physical therapy, occupational therapy, and vision‑supportive measures. Some trials are exploring lysosomal enzyme enhancers or gene‑replacement strategies, but these are experimental.
Because mucolipidosis type IV is autosomal recessive, each child of carrier parents has a 25 % chance of being affected. Genetic testing of both parents and carrier screening for future pregnancies can inform reproductive decisions. Prenatal testing or pre‑implantation genetic diagnosis can identify affected embryos early.===
Patients typically show progressive neurodevelopmental delay, motor skill regression, speech impairment, and visual problems such as nystagmus or retinal degeneration. Physical features may include coarse facial features, joint stiffness, and mild skeletal abnormalities.
Diagnosis involves a combination of clinical evaluation, imaging (MRI may show brain atrophy), and biochemical tests showing elevated lysosomal substrates. Definitive confirmation comes from sequencing the MCOLN1 gene to identify pathogenic mutations.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA